Monthly Archives: August 2018

Atlas Mara Limited Announces Notice of H1 2018 Results

2018 H1 Results Release Date and Conference Call Details

TORTOLA, BRITISH VIRGIN ISLANDS / ACCESSWIRE / August 29, 2018 / Atlas Mara Limited (“Atlas Mara” or the “Company”), the sub-Saharan Africa financial services group, will be releasing its Half Year 2018 results on 5 September 2018. In connection with the publication of its results the Company will be holding a conference call for investors at 10am EST / 3pm BST on 5 September 2018. Details for the conference call are below.

Conference Call Details:

United States: +1 (631) 913 1422
United Kingdom: +44 3333000804
Participant PIN Code: 39935625#
Date: Wednesday, 5 September 2018
Start time: 10am EST / 3pm BST

Contacts

Investors

Kojo Dufu, +1 212 883 4330

Media

Teneo Blue Rubicon, +44 (0)207 4203142
Anthony Silverman

About Atlas Mara

Atlas Mara Limited (LSE: ATMA) is a financial services institution listed on the London Stock Exchange. Its vision is to create sub-Saharan Africa’s premier financial services institution through organic and inorganic growth by combining the best of global institutional knowledge with extensive local insights. With a presence in seven sub-Saharan countries, Atlas Mara aims to be a positive disruptive force in the markets in which we operate by leveraging technology to provide innovative and differentiated product offerings, excellent customer service and accelerate financial inclusion in the countries in which the Company operates. For more information, visit www.atlasmara.com.

SOURCE: Atlas Mara Limited

ReleaseID: 511001

Albany Osteopath Treats Occupational Head Aches & Migraine Pain

Better Bodies Osteo, a professional osteopathic clinic in Albany, Auckland, seeks to increase awareness for osteopathic services treating occupational pain, in particular headaches and migraines.

Auckland, New Zealand – August 29, 2018 /PressCable/ —

Better Bodies Osteo, a professional osteopathic clinic based in Albany on Auckland’s North Shore, seeks to increase awareness for osteopathic services treating chronic occupational pain, in particular headaches and migraines.

More information can be found at https://www.betterbodiesosteo.com/

Qualified and registered osteopath Mr Ray Daniels stated, “Awareness of osteopathy as a potential treatment for headaches and migraine is low, yet it can be a very easy and timely intervention to abort headache symptoms and improve patient well-being.”

Migraine is a common disorder with a prevalence in the population of 6% in men and 18% in women. Studies comparing the efficacy of osteopathic manipulative treatment (OMT), drugs (triptans) and sham therapies demonstrated that there was a significant difference between the group being treated with OMT compared to the drug and sham therapy groups, suggesting that OMT can be considered a valid procedure for the management of patients with migraine. Headaches often have more than one cause—physical, psychological, and pharmacological. Each cause requires treatment. Mr Daniels starts by systematically eliminating specific headache triggers to arrive at the root cause of the issue.

Osteopathy treatment is administered through drug-free, non-invasive manual medicine that focuses on total body health by treating and strengthening the musculoskeletal framework, which includes the joints, muscles and spine. Osteopathy is a unique holistic (whole body) approach to health care. Osteopaths do not simply concentrate on treating the problem area, but use manual techniques to balance all the systems of the body, to provide overall good health and well-being. It is a form of medicine that focuses on the cause of illness. In effect, it is a science and philosophy of the human body.

Office workers and those suffering from chronic conditions, particularly headache and migraine may be able to find relief for their pain through non-invasive osteopathic treatments. My Daniels encourages patients to contact Better Bodies Osteo for special osteopathy treatments designed to promote better musculoskeletal health while at work for an enhanced sense of wellbeing.

To book an appointment with Better Bodies Osteo and find out more about how osteopathy treatment works for headache and migraine, simply visit the website at the link provided above.

https://www.betterbodiesosteo.com/

Contact Info:
Name: Ray Daniels
Email: betterbodiesosteo@gmail.com
Organization: Better Bodies OSTEO
Address: 7a Piermark Drive Albany, Auckland, Auckland 0632, New Zealand
Phone: +64-20-4094-4889

For more information, please visit https://www.betterbodiesosteo.com/

Source: PressCable

Release ID: 399698

NEL ICO: ”How NEL Network is Empowering Communities with Blockchain Based Microfinance”

With the Latest Findex Reports Estimating Around 2 Billion People Across the Globe Without Access to Any Banking or Financial Services, Singapore Based NEL (New Economy Ledger) Foundation, is Taking Unique Initiatives to Empower Communities in Developing Countries with its Blockchain Based Innovative Microfinance Solution

SINGAPORE / ACCESSWIRE / August 29, 2018 / Banking and financial services are quintessential to progress and development, however, despite efforts of providing mainstream financial services to communities in developing economies the recent findex reports present disappointing figures. With over 2 billion people – mostly in developing countries – with no access to any form of financial or banking services financially empowering rural and semi-urban communities in developing economies yet remains a challenge; not to mention the fact that such acute lack of financial services is an impediment to growth diminishing effective production.

Though microfinance models like that of the Gramin Bank (founded by Mohammad Yunus who was awarded a Nobel in Economics for his efforts) in Bangladesh have been instrumental in providing such services there is yet a long way to go. Integrating Blockchain technology with its innovative microfinance model, NEL, a Singapore based blockchain project is developing a unique mechanism to empower such communities by providing access to secure and better financial services by ensuring better interest rates for borrowers and also motivating lenders by safeguarding their interests.

The absence of any regulated or quality financial institution in communities allows unauthorized lending sharks to exploit those in need by levying exorbitantly high-interest rates. NEL identifies the problems facing such communities including the issues that limit the extent and reach of financial institutions in such communities.

Addressing these issues, the NEL whitepaper promises operating with comparatively much better interest rates for borrowers and also provides exclusive benefits to the lenders. By creating a robust, intuitive and interactive ecosystem leveraging the blockchain technology it ensures elimination of unnecessary costs incurred on ledger upkeeping, account maintenance, and sums lost to transaction processing and third-party intermediaries.

Evan Davis, CEO NEL, says: “NEL will be the first microfinance lending organization catering particularly to developing economies. We will be offering practical solutions to the loss of productivity suffered by the microfinance organizations and all NEL users will be able to lend with no risk to developing communities while earning interest.”

Tapping Into An Emerging and Expanding Multi-Billion Dollars Market

Microfinance has emerged as an effective solution and that has inspired the development of many microcredit and finance institutions in past two decades. In 2016 an estimated 132 million people were taking services from various microfinance institutions as the overall cumulative financial credit portfolio of such institutions was calculated to be more than 100 Billion Dollars. A +9.4% increase in the credit portfolio owing to a +9.6% increase in the number of borrowers is a strong and positive indicator of the growth and potentials of the microfinance market. South East Asia is the major hub of microfinance institutions with the two countries India and Bangladesh recording highest borrowings and an overwhelming growth rate of 23%.

This is but the tip of the iceberg as despite an unprecedented growth the microfinance institutions manage to reach out to only 20% of the poor and underdeveloped communities in developing economies. Moreover, as only 63% people in developing countries have access to something as basic as a bank account the World Bank through its Universal Financial Access 2020 initiative has committed to enable 1 billion people to get a transaction account.

NEL: Offering a Blockchain based secure and transparent Microfinance solution

Bridging the gap, NEL is creating a platform bringing both the lenders and borrowers together. With Blockchain technology it makes the rather complex processes simpler, secure, and more transparent. With blockchain, the NEL platform will significantly reduce the operational costs involved which in turn will enable them to operate with nominal loan processing charges and fees. It also claims stand out and ahead of the competition by offering quick and seamless payment processing, low transaction fees, and most importantly a high level of security using NEM blockchain features.

Built on the NEM blockchain technology the NEL platform will be powered by unique ‘NEL tokens’ which have multiple functions on the platform like allowing members to receive privileges on the allocation of smart contracts, the payment of interest by borrowers, receiving profits on the funds loaned and more. The NEL tokens initially valuing 1 NEM are to be developed as dedicated tokens and will be exchangeable and tradable in the open market. The platform will also feature a unique NEL USD token which will be pegged to the fiat currency; 1 NEL USD valuing $1 USD. While the NEL USD will protect borrowers from market volatility as the contracts and lending will be carried out in NEL USD.

The two mosaics/tokens will compliment each other on the platform and have been developed to provide both borrowers and lenders with a comprehensive solution which offers flexibility and is scalable in the long run. Moreover, all members will have access to a dedicated highly secure NEL token wallet which can be accessed from both desktops and mobile devices making it further easy for users to initiate and track transactions and get access to all features on the platform.

NEL ICO: An invitation to participate in the Microfinance revolution

NEL has already announced the launch of an ICO seeking funds to further develop the NEM platform. The ICO crowdsale is due to launch 15 September 2018 and offering benefits to all early investors, those participating in NEL tokensale within the first two weeks get an exclusive bonus of up to 30%.

Get more information about the promising NEL project and their related developments, visit the NEL website here https://nel.network.

Contact: contact@nel.network

Website: https://nel.network

SOURCE: NEL Network

ReleaseID: 510988

Swiss online marketplace announced an 18% off on Victorinox and Wenger products

Swiss web store, Swiss Made Direct, launched an 18% discount on Victorinox and Wenger watches and gear. All of these products are representing classic Swiss quality, functionality, and durability.

Luzern, Switzerland – August 29, 2018 /PressCable/ —

The largest Swiss online web store, Swiss Made Direct, has announced an 18% Off on prestigious Swiss made watches and equipment – Victorinox and Wenger. The newest collections of Victorinox watches (I.N.O.X.) are the synonym for durability, performance, and functionality. By the time these timepieces end up in the market, they’ve passed 130 stringent endurance tests. Half of the watches have been burned in the process, which speaks for itself about the reliability and strength of those which “survived”.

Speaking about it, the CEO of Swiss Made Direct said: “Besides the long tradition of Victorinox, they’ve managed to adapt to modern trends by combining classic Swiss originality and quality with the newest design. On the top of that, each of their I.N.O.X. Series is the absolute masterpiece regarding endurance and functionality. These watches have passed more than 100 durability tests, which differs them from many other watch brands. Therefore, Swiss Made Direct decided, together with the marketing team, to get a discount on these watches, in order to make them more approachable for our loyal customers.

Wenger became a part of Victorinox family in 2005. Since then, they are focusing on producing their best products – watches, and gear. Wenger women and men watch collections are combining different styles with classic, striking Swiss design. But, most importantly, the quality is the same is as it was always. On the other hand, their traveling and business gear is also carefully made for different situations, whether you need a backpack for a picnic or suitcase for a job meeting.

CEO of Swiss Made Direct added: “Wenger, as a part of Victorinox family, is also on the very top of Swiss watches and gear industry. Same as Victorinox, they’ve managed to answer to the metropolitan trends, while remaining loyal to traditional Swiss quality and watchmaking. Also, their gear and equipment provide ultimate comfort and space for all of your accessories and clothes. Since Wenger is also the part of Victorinox, it was logical to get a discount on these products, too. Customers are very well aware of the quality of Wenger products, and in this way, they’ll get closer to it.

Contact Info:
Name: Milos Paskas
Email: milosp@swissmade.direct
Organization: Swiss Made Trading
Address: 1 Littauerboden, Luzern, Luzern 6014, Switzerland

For more information, please visit https://swissmade.direct/

Source: PressCable

Release ID: 399951

First Patient Dosed in Phase II Clinical Trial in Duchenne Muscular Dystrophy

MELBOURNE, AUSTRALIA / ACCESSWIRE / August 29, 2018 / Antisense Therapeutics (ASX: ANP) today announced dosing of the first patient in a Phase II clinical trial of its immunomodulatory therapy, ATL1102, in patients with Duchenne Muscular Dystrophy (DMD).

Commencement of the trial represents an important development milestone for the Company and for patients seeking better and safer treatments.

ATL1102 is an inhibitor of CD49d expression on certain immune cells (T cells). DMD patients who have a greater number of T cells with high levels of CD49d on their surface have more severe and rapid disease progression.

ATL1102 is being developed as a treatment for the inflammation that exacerbates muscle fibre damage in DMD patients, currently treated with corticosteroids. Corticosteroids have a range of serious side effects when used for a prolonged period as required in DMD, and do not appear to be as effective in patients with a greater number T cells that express high levels of CD49d. ATL1102 was previously shown to be a highly active drug with potent effects in reducing inflammatory processes in Multiple Sclerosis patients.

The six-month dosing trial of ATL1102 in 9 non-ambulant patients with DMD aged between 10 and 18 years is being conducted at the neuromuscular centre of the Royal Children’s Hospital in Melbourne (RCH), which operates the largest clinic in the southern hemisphere treating children with DMD. The Investigators for the study are Dr Ian Woodcock, a Neuromuscular Fellow at the RCH and Professor Monique Ryan, Director of the Neurology Department at RCH.

The primary endpoints of the trial relate to the safety and tolerability of ATL1102. The efficacy of ATL1102 will also be assessed in terms of its effects on markers of inflammation, muscle damage, and disease progression. Further details on the trial are available on the Australian New Zealand Clinical Trials Registry (http://www.anzctr.org.au).

Currently, there are a limited number of anti-inflammatory drugs in clinical development for DMD and ATL1102 is the only CD49d targeting drug undergoing clinical trials in DMD patients.

Mark Diamond, CEO of Antisense Therapeutics said: “We are very pleased to report that patient recruitment and dosing are now underway being a key inflection point in the Company’s progress. We look forward to trial data becoming available and providing further market updates on trial progress. Achievement of this important milestone positions us as a clinical stage company in DMD committed to the pursuit of an effective treatment for a devastating disease that is desperately under-served by existing therapies.”

About Antisense Therapeutics Limited (ASX: ANP) is an Australian publicly listed biopharmaceutical company, developing and commercialising antisense pharmaceuticals for large unmet markets. The products are in-licensed from Ionis Pharmaceuticals Inc. (IONS), world leaders in antisense drug development and commercialisation. ATL1102 (injection) has successfully completed a Phase II efficacy and safety trial, significantly reducing the number of brain lesions in patients with relapsing-remitting multiple sclerosis (RRMS). ATL1103 drug designed to block GHr production successfully reduced blood IGF-I levels in Phase II clinical trials in patients with the growth disorder acromegaly. The Company is conducting a Phase II clinical trial of ATL1102 in DMD patients at the Royal Children’s Hospital, Melbourne.

About ATL1102 ATL1102 is an antisense inhibitor of CD49d, a subunit of VLA-4 (Very Late Antigen-4). Antisense inhibition of VLA-4 expression has demonstrated activity in a number of animal models of inflammatory disease including asthma and MS with the MS animal data having been published in a peer-reviewed scientific journal. ATL1102 was shown to be highly effective in reducing MS lesions in a Phase IIa clinical trial in RR-MS patients. The ATL1102 Phase IIa clinical data has been published in the medical Journal Neurology (Limmroth, V. et al. Neurology, 2014; 83(20): 1780-1788).

About DMD Duchenne Muscular Dystrophy (DMD) is an X-linked disease that affects 1 in 3600 to 6000 live male births (Bushby et al., 2010). DMD occurs as a result of mutations in the dystrophin gene which causes the reduction in or absence of the dystrophin protein. Children with DMD have dystrophin-deficient muscles and are susceptible to contraction-induced injury to muscle that triggers the immune system which exacerbates muscle damage as summarized in a publication co-authored by the Director of the FDA CDER (Rosenberg et al., 2015). Ongoing deterioration in muscle strength affects lower limbs leading to impaired mobility, and also affects upper limbs, leading to further loss of function and self-care ability. The need for wheelchair use can occur in early teenage years with a mean age of 13, with respiratory, cardiac, cognitive dysfunction also emerging. Patients with a greater number of immune T cells expressing high levels of CD49d have more severe and progressive disease and are wheelchair bound by the age of 10 (Pinto Mariz et al., 2015). With no intervention, the mean age of life is approximately 19 years. The management of the inflammation associated with DMD is currently addressed via the use of corticosteroids, however they are acknowledged as providing insufficient efficacy and are associated with significant side effects. As a consequence, there is an acknowledged high need for new therapeutic approaches for the treatment of inflammation associated with DMD. https://mdaustralia.org.au.

Rosenberg AS, Puig M, Nagaraju K, et al. Immune-mediated pathology in Duchenne muscular dystrophy. Sci Transl Med 2015, 7: 299rv4.

Pinto-Mariz F, Carvalho LR, Araújo AQC, et al. CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy. Skeletal Muscle 2015, 5: 45-55

SOURCE: Antisense Therapeutics Limited

ReleaseID: 510986

Dried Fruit & Nuts Market 2018 Global Trend, Segmentation and Opportunities Forecast To 2025

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

Pune, India – August 29, 2018 /MarketersMedia/ —

This report studies the global Dried Fruit & Nuts market status and forecast, categorizes the global Dried Fruit & Nuts market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Dried Fruit & Nuts market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report
Sun-Maid
Arimex
Olam International
Sunbeam Foods
Diamond Foods
Archer Daniels Midland
Kanegrade
Graceland
Hines Nut Company
H.B.S. Foods

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2820945-global-dried-fruit-nuts-market-research-report-2018

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
by Nuts
Pistachio
Badam
Walnut
Apricot Kernel
Chinese Chestnut
Peanut
Hazelnut
Macadamia
Cashew
Other Nuts
by Dried Fruits
Dried Dates
Dried Grape
Dried Prunes
Dried Apricots
Dried Figs
Dried Longan
Dried Jujube
Dried Persimmon
Other Dried Fruit
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Household
Commercial

Table of Contents

Global Dried Fruit & Nuts Market Research Report 2018
1 Dried Fruit & Nuts Market Overview
1.1 Product Overview and Scope of Dried Fruit & Nuts
1.2 Dried Fruit & Nuts Segment by Type (Product Category)
1.2.1 Global Dried Fruit & Nuts Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Dried Fruit & Nuts Production Market Share by Type (Product Category) in 2017
1.2.3 Pistachio
1.2.4 Badam
1.2.5 Walnut
1.2.6 Apricot Kernel
1.2.7 Chinese Chestnut
1.2.8 Peanut
1.2.9 Hazelnut
1.2.10 Macadamia
1.2.11 Cashew
1.2.12 Other Nuts
1.3 Dried Fruit & Nuts Segment by Dried Fruits
1.3.1 Dried Dates
1.3.2 Dried Grape
1.3.3 Dried Prunes
1.3.4 Dried Apricots
1.3.5 Dried Figs
1.3.6 Dried Longan
1.3.7 Dried Jujube
1.3.8 Dried Persimmon
1.3.9 Other Dried Fruit
1.2.5.1
1.4 Global Dried Fruit & Nuts Segment by Application
1.4.1 Dried Fruit & Nuts Consumption (Sales) Comparison by Application (2013-2025)
1.4.2 Household
1.4.3 Commercial
1.5 Global Dried Fruit & Nuts Market by Region (2013-2025)
1.5.1 Global Dried Fruit & Nuts Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.5.2 North America Status and Prospect (2013-2025)
1.5.3 Europe Status and Prospect (2013-2025)
1.5.4 China Status and Prospect (2013-2025)
1.5.5 Japan Status and Prospect (2013-2025)
1.5.6 Southeast Asia Status and Prospect (2013-2025)
1.5.7 India Status and Prospect (2013-2025)
1.6 Global Market Size (Value) of Dried Fruit & Nuts (2013-2025)
1.6.1 Global Dried Fruit & Nuts Revenue Status and Outlook (2013-2025)
1.6.2 Global Dried Fruit & Nuts Capacity, Production Status and Outlook (2013-2025)

2 Global Dried Fruit & Nuts Market Competition by Manufacturers
2.1 Global Dried Fruit & Nuts Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Dried Fruit & Nuts Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Dried Fruit & Nuts Production and Share by Manufacturers (2013-2018)
2.2 Global Dried Fruit & Nuts Revenue and Share by Manufacturers (2013-2018)
2.3 Global Dried Fruit & Nuts Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Dried Fruit & Nuts Manufacturing Base Distribution, Sales Area and Product Type
2.5 Dried Fruit & Nuts Market Competitive Situation and Trends
2.5.1 Dried Fruit & Nuts Market Concentration Rate
2.5.2 Dried Fruit & Nuts Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Dried Fruit & Nuts Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Dried Fruit & Nuts Capacity and Market Share by Region (2013-2018)
3.2 Global Dried Fruit & Nuts Production and Market Share by Region (2013-2018)
3.3 Global Dried Fruit & Nuts Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Dried Fruit & Nuts Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Dried Fruit & Nuts Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Dried Fruit & Nuts Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Dried Fruit & Nuts Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Dried Fruit & Nuts Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Dried Fruit & Nuts Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Dried Fruit & Nuts Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Dried Fruit & Nuts Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Dried Fruit & Nuts Consumption by Region (2013-2018)
4.2 North America Dried Fruit & Nuts Production, Consumption, Export, Import (2013-2018)
4.3 Europe Dried Fruit & Nuts Production, Consumption, Export, Import (2013-2018)
4.4 China Dried Fruit & Nuts Production, Consumption, Export, Import (2013-2018)
4.5 Japan Dried Fruit & Nuts Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Dried Fruit & Nuts Production, Consumption, Export, Import (2013-2018)
4.7 India Dried Fruit & Nuts Production, Consumption, Export, Import (2013-2018)

5 Global Dried Fruit & Nuts Production, Revenue (Value), Price Trend by Type
5.1 Global Dried Fruit & Nuts Production and Market Share by Type (2013-2018)
5.2 Global Dried Fruit & Nuts Revenue and Market Share by Type (2013-2018)
5.3 Global Dried Fruit & Nuts Price by Type (2013-2018)
5.4 Global Dried Fruit & Nuts Production Growth by Type (2013-2018)

6 Global Dried Fruit & Nuts Market Analysis by Application
6.1 Global Dried Fruit & Nuts Consumption and Market Share by Application (2013-2018)
6.2 Global Dried Fruit & Nuts Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

……Continued

Access Complete Report @ https://www.wiseguyreports.com/reports/2820945-global-dried-fruit-nuts-market-research-report-2018

Contact Info:
Name: Norah Trent
Email: Sales@Wiseguyreports.Com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349 (US) +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/dried-fruit-nuts-market-2018-global-trend-segmentation-and-opportunities-forecast-to-2025/400103

For more information, please visit https://www.wiseguyreports.com/

Source: MarketersMedia

Release ID: 400103

Depilatories Market 2018 Global Trend, Segmentation And Opportunities Forecast To 2023

Depilatories -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

Pune, India – August 29, 2018 /MarketersMedia/ —

Depilatories Industry

Description

Wiseguyreports.Com Adds “Depilatories -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

This report studies the global market size of Depilatories in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Depilatories in these regions. 
This research report categorizes the global Depilatories market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

A depilatory is a cosmetic preparation used to remove hair from the skin on the body. Currently, common active ingredients are calcium thioglycolate or potassium thioglycolate, which breaks down the disulfide bonds in keratin and weakens the hair so that it is easily scraped off where it emerges from the hair follicle. 

In terms of geography, Europe led the global depilatory products market. The growing preference for staying well-groomed is one of the key factors driving this market’s growth in Europe. Moreover, increasing awareness among the consumers of depilatories as efficient, safe, and convenient options to stay well-groomed will propel the growth prospects of this market in the region. 

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3366471-global-depilatories-market-insights-forecast-to-2025

The various contributors involved in the value chain of Depilatories include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Depilatories include 

Andrea 
Church & Dwight 
Dabur International 
Jolen 
L’Oreal 
Nads 
Reckitt Benckiser Group 
Revitol 
Sally Hansen 
Procter & Gamble 
Veet 
Parissa 
Nair 
Moom 
Surgi-cream

Market Size Split by Type 
Creams Type 
Gels Type 
Lotions Type 

Market Size Split by Application 
For Male 
For Female

The study objectives of this report are: 
To study and analyze the global Depilatories market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. 
To understand the structure of Depilatories market by identifying its various subsegments. 
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). 
Focuses on the key global Depilatories manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. 
To analyze the Depilatories with respect to individual growth trends, future prospects, and their contribution to the total market. 
To project the value and volume of Depilatories submarkets, with respect to key regions (along with their respective key countries). 
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. 
To strategically profile the key players and comprehensively analyze their growth strategies.

Leave a Query @ https://www.wiseguyreports.com/enquiry/3366471-global-depilatories-market-insights-forecast-to-2025

Table of Contents

1 Study Coverage 
1.1 Depilatories Product 
1.2 Key Market Segments 
1.3 Key Manufacturers Covered 
1.4 Market by Type 
1.4.1 Global Depilatories Market Size Growth Rate by Type 
1.4.2 Creams Type 
1.4.3 Gels Type 
1.4.4 Lotions Type 
1.5 Market by Application 
1.5.1 Global Depilatories Market Size Growth Rate by Application 
1.5.2 For Male 
1.5.3 For Female 
1.6 Study Objectives 
1.7 Years Considered

2 Executive Summary 
2.1 Global Depilatories Market Size 
2.1.1 Global Depilatories Revenue 2016-2025 
2.1.2 Global Depilatories Sales 2016-2025 
2.2 Depilatories Growth Rate by Regions 
2.2.1 Global Depilatories Sales by Regions 
2.2.2 Global Depilatories Revenue by Regions

….

11 Company Profiles 
11.1 Andrea 
11.1.1 Andrea Company Details 
11.1.2 Company Description 
11.1.3 Sales, Revenue and Gross Margin of Depilatories 
11.1.4 Depilatories Product Description 
11.1.5 Recent Development 
11.2 Church & Dwight 
11.2.1 Church & Dwight Company Details 
11.2.2 Company Description 
11.2.3 Sales, Revenue and Gross Margin of Depilatories 
11.2.4 Depilatories Product Description 
11.2.5 Recent Development 
11.3 Dabur International 
11.3.1 Dabur International Company Details 
11.3.2 Company Description 
11.3.3 Sales, Revenue and Gross Margin of Depilatories 
11.3.4 Depilatories Product Description 
11.3.5 Recent Development 
11.4 Jolen 
11.4.1 Jolen Company Details 
11.4.2 Company Description 
11.4.3 Sales, Revenue and Gross Margin of Depilatories 
11.4.4 Depilatories Product Description 
11.4.5 Recent Development 
11.5 L’Oreal 
11.5.1 L’Oreal Company Details 
11.5.2 Company Description 
11.5.3 Sales, Revenue and Gross Margin of Depilatories 
11.5.4 Depilatories Product Description 
11.5.5 Recent Development 
11.6 Nads 
11.6.1 Nads Company Details 
11.6.2 Company Description 
11.6.3 Sales, Revenue and Gross Margin of Depilatories 
11.6.4 Depilatories Product Description 
11.6.5 Recent Development 
11.7 Reckitt Benckiser Group 
11.7.1 Reckitt Benckiser Group Company Details 
11.7.2 Company Description 
11.7.3 Sales, Revenue and Gross Margin of Depilatories 
11.7.4 Depilatories Product Description 
11.7.5 Recent Development 
11.8 Revitol 
11.8.1 Revitol Company Details 
11.8.2 Company Description 
11.8.3 Sales, Revenue and Gross Margin of Depilatories 
11.8.4 Depilatories Product Description 
11.8.5 Recent Development 
11.9 Sally Hansen 
11.9.1 Sally Hansen Company Details 
11.9.2 Company Description 
11.9.3 Sales, Revenue and Gross Margin of Depilatories 
11.9.4 Depilatories Product Description 
11.9.5 Recent Development 
11.10 Procter & Gamble 
11.10.1 Procter & Gamble Company Details 
11.10.2 Company Description 
11.10.3 Sales, Revenue and Gross Margin of Depilatories 
11.10.4 Depilatories Product Description 
11.10.5 Recent Development 
11.11 Veet 
11.12 Parissa 
11.13 Nair 
11.14 Moom 
11.15 Surgi-cream

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3366471

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Contact Info:
Name: Norah Trent
Email: Sales@Wiseguyreports.Com
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349 (US) +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/depilatories-market-2018-global-trend-segmentation-and-opportunities-forecast-to-2023/400106

For more information, please visit https://www.wiseguyreports.com/sample-request/3366471-global-depilatories-market-insights-forecast-to-2025

Source: MarketersMedia

Release ID: 400106

Portable Oxygen Concentrators 2018 Global Market Net Worth US$ 2.9 billion Forecast By 2023

WiseGuyReports.Com Publish a New Market Research Report On –“ Portable Oxygen Concentrators 2018 Global Market Net Worth US$ 2.9 billion Forecast By 2023”.

Pune, India – August 29, 2018 /MarketersMedia/ —

Description:-

The 2017 study has 493 pages, 201 tables and figures. Worldwide markets are poised to achieve continuing growth. Portable oxygen concentrators support lifestyle for medical oxygen users.

Portable oxygen concentrators are approved by the FAA for use on airlines. People on oxygen wish to continue usual activities. Distributors are concentrated on determining which portable oxygen concentrator allows the freedom to continue a meaningful lifestyle. There are two types of oxygen delivery systems providing supplemental oxygen therapy; continuous flow (Respironics SimplyGo, SeQual Eclipes,) and pulse dose (Inogen One G3, AirSep Freestyle, Invacare XPO2).

A pulse dose system is the most commonly used portable oxygen concentrator. Because of its light weight and long battery life, some lasting up to 8 hours on a single battery charge, the units are preferred by patients. Some oxygen users require continuous flow oxygen due to their diagnosis or illness progress. Continuous flow is required by any oxygen user who is titrating oxygen into their CPAP or BiPAP therapy.

Major factors driving the market for portable oxygen concentrators include device ability to provide oxygen under all circumstances. The worldwide aging population benefits from supplemental medical oxygen. An increase in the number of people with COPD and other respiratory diseases are a direct market driver. Advantages of portable oxygen concentrator devices are that they weigh less, are easy to use. They are affordable.

The complexion of the home oxygen market is changing. Home oxygen markets have been predicated on a dealer infrastructure. These dealers get reimbursed for regular deliveries of oxygen used in the home, and for supplemental oxygen so the patient can go out, buy groceries, go to the movies, and visit family for a short time. The advent of reliable, inexpensive portable home oxygen concentrators has changed the market dynamic significantly.

…….

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/2115780-portable-oxygen-concentrators-market-shares-strategies-and-forecasts-worldwide-2017-to

For more information or any query mail at sales@wiseguyreports.com

Companies Profiled

Market Leaders
• Inogen
• Philips / Respironics
• Chart / Caire / SeQual
• AirSep
• NTK
• Drive / Devilbiss
• O2Concepts Oxlife

Market Participants
• Applied Home Healthcare Equipment
• Besco
• Chart Industries
• Drive DeVilbiss Healthcare
• First Class Medical
• Foshan Keyhub Electronic Industries Co., Ltd.
• Gardner Denver / Thomas Compressors
• GSE
• Inogen
• Invacare
• Jiuxin Medical
• Leistung Engineering
• Longfian Scitech
• Merits
• Nidek Medical
• NTK
• Precision Medical
• O2 Concepts
• Philips Healthcare / Respironics
• ResMed
• Zadro Health Solutions

Key Topics
• Oxygen Concentrator
• Portable Oxygen Concentrators
• Homecare
• Home Oxygen
• Home Medical Equipment
• Oxygen Therapy
• Managed Care
• Non-Acute Health Care
• Unified Supply Network
• Portable Pulsed Delivery Oxygen
• Portable Continuous Pressure Oxygen
• Portable Pulsed Oxygen
• Patients on Oxygen
• Home Oxygen Reimbursement
• Homefill Oxygen Concentrator
• Portable Oxygen Concentrators Market Share
• Portable Oxygen Concentrators Market Forecasts

Complete Report Details @ https://www.wiseguyreports.com/reports/2115780-portable-oxygen-concentrators-market-shares-strategies-and-forecasts-worldwide-2017-to

Table Of Contents – Major Key Points

1. Portable Oxygen Concentrator Market Description And Market Dynamics 41
1.1 Homecare Market Growth Factors 41
1.1.1 Growth In Population Over Age 65 43
1.2 Oxygen Concentrator Uses 43
1.2.1 Portable Oxygen Concentrator Functions 44
1.2.2 Separation Of Oxygen From Air 45
1.2.3 Technical Trade-Offs Necessary To Design A Portable Oxygen Concentrator (POC) 45
1.3 Oxygen Concentrator Insurance Coverage 46
1.3.1 Oxygen Concentrator CMS HCPCS Code 49
1.3.2 Medicare Reimbursement 49
1.4 The Goal of Oxygen Therapy 49
1.4.1 How To Change The Amount of Oxygen In The Air We Breathe 50
1.4.2 Oxygen Concentrator Components 51
1.4.3 Lifestyle in the Home Health Care Business 53
1.4.4 Portable Oxygen Concentrator Airline Travel 53
1.4.5 Portable Oxygen Concentrator Pulse Mode 55
1.4.6 Continuous Flow Portable Oxygen Concentrator 55
1.5 Types of Oxygen Systems 56
1.5.1 Treatment Trends. 56
1.5.2 Technological Trends. 57
1.5.3 Health Care Cost Containment Trends. 57
1.5.4 Society’s Mainstreaming of People with Disabilities. 58
1.5.5 Distribution Channels 58
1.5.6 Oxygen Therapy Systems 58
1.6 Oxygen Concentrator Applicable Population 59
1.7 Home Oxygen Concentrator Equipment Medicare Reimbursement 60
1.7.1 Home Medical Equipment Market 60
1.7.2 Home Health Care 61
1.7.3 Third-party reimbursement 62
1.7.4 Portable Oxygen Patients Need Stationary Oxygen Concentrator’s at Night 63
1.8 Treatment Trends 63
1.8.1 Competition Forms Basis Of U.S. Medical Care Services Delivery 64
1.9 European Homecare Market Trends 65
1.10 Marketing Globally 66
1.11 Market Drivers For Healthcare Cost Containment 68

…….

5. Portable Oxygen Equipment Company Description 348
5.1 Applied Home Healthcare Equipment 348
5.2 Besco 349
5.3 Chart Industries 351
5.3.1 Chart / Caire Medical 352
5.3.2 Chart Industries Revenue 353
5.3.3 Chart Industries Respiratory Sales 357
5.3.4 Chart Caire / AirSep / Sequal 358
5.3.5 Chart Industries Product Groups 359
5.3.6 Chart Industries Cold Boxes 361
5.3.7 Chart Industries Global Presence 362
5.3.8 Chart Industries Markets 363
5.3.9 Chart Industries Segments and Products 363
5.3.10 Chart Industries Process Systems 364
5.3.11 Chart Industries Distribution and Storage Segment 365
5.3.12 Chart Industries Cryogenic Bulk Storage Systems 365
5.3.13 Chart Industries Storage And End-Use Of Hydrocarbon And Industrial Gases 366
5.3.14 Chart Industries / AirSep 367
5.3.15 Chart Industries/Caire Liquid Oxygen Continuous Flow/Demand Flow Versatility 368
5.3.16 CAIRE / SeQual Technologies 368
5.3.17 Chart Industries / SeQual 369
5.3.18 SeQual Oxygen Systems 370
5.4 Drive DeVilbiss Healthcare 370
5.4.1 DeVilbiss Healthcare Moves Production Back to the USA 372
5.4.2 Drive Medical Facilities Locations 374
5.4.3 Drive Medical Markets 374
5.4.4 Drive Medical 375
5.4.5 Drive Medical / DeVilbiss Healthcare, Worldwide Leadership in Respiratory, Sleep and Durable Medical Products 375
5.4.6 Drive Medical Product Line 376
5.5 First Class Medical 377
5.5.1 1st Class Medical Used and Refurbished Concentrators: 377
5.6 Foshan Keyhub Electronic Industries Co., Ltd. 378
5.6.1 Foshan Keyhub Shunde, Guangdong Province, China 380
5.6.2 Keyhub Shunde Oxygen Concentrators And Inner Core Component Production Capacity 380
5.7 Gardner Denver / Thomas Compressors 385
5.7.1 Gardner Denver Thomas Medical 393
5.7.2 Gardner Denver Thomas Engineering Department 399
5.7.3 Gardner Denver Thomas OEM 399
5.7.4 Gardner Denver Thomas Product Industries 400
5.7.5 Gardner Denver Thomas Respiratory Therapy Product Design 406
5.7.6 Gardner Denver Thomas Embedded Control Systems 406
5.8 GSE 407
5.9 Inogen 409
5.9.1 Inogen Rentals 414
5.9.2 Inogen Manufacturing Capacity 415
5.9.3 Inogen Expands Manufacturing Capacity to Accommodate Growth 417
5.9.4 5.7.4 Inogen Direct-To-Consumer Marketing Strategies 417
2.7.5 Inogen Acquires Breathe Oxygen Services 419
5.9.5 Inogen One G3 Versatile Portable Oxygen Concentrator 420
5.9.6 Inogen Is Reliable, Trusted, And Proven 421
5.10 Invacare 423
5.10.1 5.8.1 Invacare Revenue 424
2.7.2 Invacare Quote to Order Wheelchair Process 425
5.10.2 Invacare Non-Delivery Oxygen 425
5.10.3 Invacare Business 427
5.10.4 Invacare Growth 430
5.10.5 Invacare Geographical Segments And Product Categories 431
5.10.6 Invacare Mobility And Seating Products and Status of Consent Decree 431
5.10.7 Invacare Lifestyle Products 433
5.10.8 Invacare Respiratory Therapy Products 435
5.10.9 Invacare Institutional Products Group (IPG) 436
5.11 Jiuxin Medical 437
5.11.1 Jiuxin Medical Jogger Portable Ventilator 437
5.11.2 Jiuxin Medical ICU Ventilator Detachable 10.4″TFT Color Screen 438
5.12 Leistung Engineering 439
5.12.1 Leistung Key Strategy 440

Continued……

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WiseGuy Research Consultant Pvt Ltd.
Address: Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
Phone: +1-646-845-9349

Source URL: https://marketersmedia.com/portable-oxygen-concentrators-2018-global-market-net-worth-us-2-9-billion-forecast-by-2023/400122

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 400122

Direct-Fed Microbials Market 2018 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2023

Direct-Fed Microbials Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

Pune, India – August 29, 2018 /MarketersMedia/ —

Summary

WiseGuyReports.com adds “Direct-Fed Microbials Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Direct-Fed Microbials Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Direct-Fed Microbials Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report focuses on the global Direct-Fed Microbials status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Direct-Fed Microbials development in United States, Europe and China.

Direct fed microbials (or probiotics) refer to living organisms and should not be confused with prebiotics, compounds that promote the growth of gut bacteria (e.g., yeast culture, oligosaccharides) but are not living organisms. It is believed that gut bacteria have requirements for specific nutrients that may not be adequately provided by the animal’s diet. Therefore, feeding these nutrients may promote the growth of gut bacteria, thereby improving the microbial profile in the gut.
Asia-Pacific has the largest global export quantity and manufacturers in Direct-Fed Microbials market, while the North America is the second sales volume market for Direct-Fed Microbials in 2017.
In the industry, JBS United profits most in 2017 and recent years, while Asahi Calpis Wellness and Koninklijke DSM N.V. ranked 2 and 3.The market share of them is 13.04%, 12.51% and 12.10% in 2017.The gap of market share is keep on enlarged due to different strategy.

The key players covered in this study
Asahi Calpis Wellness
JBS United
Adisseo (Novozymes)
Koninklijke DSM N.V.
Danisco Animal Nutrition (Dupont)
Baolai-leelai
Evonik Industries AG
Chr. Hansen
Biomin Holding GmbH
Archer Daniels Midland Company
Lallemand
Kemin Industries
Nutraferma
Novus International
Bentoli
Bio-Vet
Biowish Technologies

Market segment by Type, the product can be split into
Viable Bacteria ≤1000 million CFU/g
Viable Bacteria 1000-5000 million CFU/g
Viable Bacteria ≥5000 million CFU/g

Market segment by Application, split into
Poultry
Swine
Ruminants
Aquatic Animals
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3340187-global-direct-fed-microbials-market-size-status-and-forecast-2018-2025

Major Key Points in Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Direct-Fed Microbials Market Size Growth Rate by Type (2013-2025)
1.4.2 Viable Bacteria ≤1000 million CFU/g
1.4.3 Viable Bacteria 1000-5000 million CFU/g
1.4.4 Viable Bacteria ≥5000 million CFU/g
1.5 Market by Application
1.5.1 Global Direct-Fed Microbials Market Share by Application (2013-2025)
1.5.2 Poultry
1.5.3 Swine
1.5.4 Ruminants
1.5.5 Aquatic Animals
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Direct-Fed Microbials Market Size
2.2 Direct-Fed Microbials Growth Trends by Regions
2.2.1 Direct-Fed Microbials Market Size by Regions (2013-2025)
2.2.2 Direct-Fed Microbials Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

….

12 International Players Profiles
12.1 Asahi Calpis Wellness
12.1.1 Asahi Calpis Wellness Company Details
12.1.2 Company Description and Business Overview
12.1.3 Direct-Fed Microbials Introduction
12.1.4 Asahi Calpis Wellness Revenue in Direct-Fed Microbials Business (2013-2018)
12.1.5 Asahi Calpis Wellness Recent Development
12.2 JBS United
12.2.1 JBS United Company Details
12.2.2 Company Description and Business Overview
12.2.3 Direct-Fed Microbials Introduction
12.2.4 JBS United Revenue in Direct-Fed Microbials Business (2013-2018)
12.2.5 JBS United Recent Development
12.3 Adisseo (Novozymes)
12.3.1 Adisseo (Novozymes) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Direct-Fed Microbials Introduction
12.3.4 Adisseo (Novozymes) Revenue in Direct-Fed Microbials Business (2013-2018)
12.3.5 Adisseo (Novozymes) Recent Development
12.4 Koninklijke DSM N.V.
12.4.1 Koninklijke DSM N.V. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Direct-Fed Microbials Introduction
12.4.4 Koninklijke DSM N.V. Revenue in Direct-Fed Microbials Business (2013-2018)
12.4.5 Koninklijke DSM N.V. Recent Development
12.5 Danisco Animal Nutrition (Dupont)
12.5.1 Danisco Animal Nutrition (Dupont) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Direct-Fed Microbials Introduction
12.5.4 Danisco Animal Nutrition (Dupont) Revenue in Direct-Fed Microbials Business (2013-2018)
12.5.5 Danisco Animal Nutrition (Dupont) Recent Development
12.6 Baolai-leelai
12.6.1 Baolai-leelai Company Details
12.6.2 Company Description and Business Overview
12.6.3 Direct-Fed Microbials Introduction
12.6.4 Baolai-leelai Revenue in Direct-Fed Microbials Business (2013-2018)
12.6.5 Baolai-leelai Recent Development
12.7 Evonik Industries AG
12.7.1 Evonik Industries AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Direct-Fed Microbials Introduction
12.7.4 Evonik Industries AG Revenue in Direct-Fed Microbials Business (2013-2018)
12.7.5 Evonik Industries AG Recent Development
12.8 Chr. Hansen
12.8.1 Chr. Hansen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Direct-Fed Microbials Introduction
12.8.4 Chr. Hansen Revenue in Direct-Fed Microbials Business (2013-2018)
12.8.5 Chr. Hansen Recent Development
12.9 Biomin Holding GmbH
12.9.1 Biomin Holding GmbH Company Details
12.9.2 Company Description and Business Overview
12.9.3 Direct-Fed Microbials Introduction
12.9.4 Biomin Holding GmbH Revenue in Direct-Fed Microbials Business (2013-2018)
12.9.5 Biomin Holding GmbH Recent Development
12.10 Archer Daniels Midland Company
12.10.1 Archer Daniels Midland Company Company Details
12.10.2 Company Description and Business Overview
12.10.3 Direct-Fed Microbials Introduction
12.10.4 Archer Daniels Midland Company Revenue in Direct-Fed Microbials Business (2013-2018)
12.10.5 Archer Daniels Midland Company Recent Development
12.11 Lallemand
12.12 Kemin Industries
12.13 Nutraferma
12.14 Novus International
12.15 Bentoli
12.16 Bio-Vet
12.17 Biowish Technologies

At any Query @ https://www.wiseguyreports.com/enquiry/3340187-global-direct-fed-microbials-market-size-status-and-forecast-2018-2025

Continued….

Contact Info:
Name: NORAH TRENT
Email: Sales@wiseguyreports.com
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune – 411028
Phone: +1-646-845-9349 (US), +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/direct-fed-microbials-market-2018-global-trends-market-share-industry-size-growth-opportunities-and-forecast-to-2023/400144

For more information, please visit https://www.wiseguyreports.com/sample-request/3340187-global-direct-fed-microbials-market-size-status-and-forecast-2018-2025

Source: MarketersMedia

Release ID: 400144

Baby Apparels Market 2018 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2023

Baby Apparels Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

Pune, India – August 29, 2018 /MarketersMedia/ —

Summary

WiseGuyReports.com adds “Baby Apparels Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Baby Apparels Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Baby Apparels Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report researches the worldwide Baby Apparels market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Baby Apparels breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

Baby clothing, these colorful clothes are designed for baby boys and baby girls with various types like suits, jackets, sweaters, pants, T-shirts, etc. Cotton is the most used material of baby clothing due to its characters like sweat-absorbent, soft and comfortable. Wool, fur, linen and silk are also the major fabric materials.
With the continuous development of the economy in global market, the growth rate in recent years has declined to some extent, but the baby clothing market is relatively stable, it is expected in the next few years will continue this state.

This report focuses on the top manufacturers’ Baby Apparels capacity, production, value, price and market share of Baby Apparels in global market. The following manufacturers are covered in this report:
Carters
JoynCleon
H&M
JACADI
GAP
Gymboree
OKAIDI
Catimini
BOBDOG
Nike
Benetton
Mothercare
Name it
Nishimatsuya
Les Enphants
Oshkosh
Adidas
Disney
MIKI HOUSE
Annil
Balabala
Honghuanglan
Pepco
Dadida
Paclantic
Goodbaby
KARA BEAR
Gebitu
Dd-cat
Lionbrien

Baby Apparels Breakdown Data by Type
Cotton
Wool
Linen
Silk
Others

Baby Apparels Breakdown Data by Application
Coverall
Outerwear
Underwear
Basics

Baby Apparels Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Baby Apparels Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3339077-global-baby-apparels-market-insights-forecast-to-2025

Major Key Points in Table of Content

Global Baby Apparels Market Research Report 2018-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
1.1 Baby Apparels Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Baby Apparels Market Size Growth Rate by Type
1.4.2 Cotton
1.4.3 Wool
1.4.4 Linen
1.4.5 Silk
1.4.6 Others
1.5 Market by Application
1.5.1 Global Baby Apparels Market Size Growth Rate by Application
1.5.2 Coverall
1.5.3 Outerwear
1.5.4 Underwear
1.5.5 Basics
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Baby Apparels Production
2.1.1 Global Baby Apparels Revenue 2013-2025
2.1.2 Global Baby Apparels Production 2013-2025
2.1.3 Global Baby Apparels Capacity 2013-2025
2.1.4 Global Baby Apparels Marketing Pricing and Trends
2.2 Baby Apparels Growth Rate (CAGR) 2018-2025
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key Baby Apparels Manufacturers
2.4 Market Drivers, Trends and Issues
2.5 Macroscopic Indicator
2.5.1 GDP for Major Regions
2.5.2 Price of Raw Materials in Dollars: Evolution

….

8 Manufacturers Profiles
8.1 Carters
8.1.1 Carters Company Details
8.1.2 Company Description
8.1.3 Capacity, Production and Value of Baby Apparels
8.1.4 Baby Apparels Product Description
8.1.5 SWOT Analysis
8.2 JoynCleon
8.2.1 JoynCleon Company Details
8.2.2 Company Description
8.2.3 Capacity, Production and Value of Baby Apparels
8.2.4 Baby Apparels Product Description
8.2.5 SWOT Analysis
8.3 H&M
8.3.1 H&M Company Details
8.3.2 Company Description
8.3.3 Capacity, Production and Value of Baby Apparels
8.3.4 Baby Apparels Product Description
8.3.5 SWOT Analysis
8.4 JACADI
8.4.1 JACADI Company Details
8.4.2 Company Description
8.4.3 Capacity, Production and Value of Baby Apparels
8.4.4 Baby Apparels Product Description
8.4.5 SWOT Analysis
8.5 GAP
8.5.1 GAP Company Details
8.5.2 Company Description
8.5.3 Capacity, Production and Value of Baby Apparels
8.5.4 Baby Apparels Product Description
8.5.5 SWOT Analysis
8.6 Gymboree
8.6.1 Gymboree Company Details
8.6.2 Company Description
8.6.3 Capacity, Production and Value of Baby Apparels
8.6.4 Baby Apparels Product Description
8.6.5 SWOT Analysis
8.7 OKAIDI
8.7.1 OKAIDI Company Details
8.7.2 Company Description
8.7.3 Capacity, Production and Value of Baby Apparels
8.7.4 Baby Apparels Product Description
8.7.5 SWOT Analysis
8.8 Catimini
8.8.1 Catimini Company Details
8.8.2 Company Description
8.8.3 Capacity, Production and Value of Baby Apparels
8.8.4 Baby Apparels Product Description
8.8.5 SWOT Analysis
8.9 BOBDOG
8.9.1 BOBDOG Company Details
8.9.2 Company Description
8.9.3 Capacity, Production and Value of Baby Apparels
8.9.4 Baby Apparels Product Description
8.9.5 SWOT Analysis
8.10 Nike
8.10.1 Nike Company Details
8.10.2 Company Description
8.10.3 Capacity, Production and Value of Baby Apparels
8.10.4 Baby Apparels Product Description
8.10.5 SWOT Analysis
8.11 Benetton
8.12 Mothercare
8.13 Name it
8.14 Nishimatsuya
8.15 Les Enphants
8.16 Oshkosh
8.17 Adidas
8.18 Disney
8.19 MIKI HOUSE
8.20 Annil
8.21 Balabala
8.22 Honghuanglan
8.23 Pepco
8.24 Dadida
8.25 Paclantic
8.26 Goodbaby
8.27 KARA BEAR
8.28 Gebitu
8.29 Dd-cat
8.30 Lionbrien

At any Query @ https://www.wiseguyreports.com/enquiry/3339077-global-baby-apparels-market-insights-forecast-to-2025

Continued….

Contact Info:
Name: NORAH TRENT
Email: Sales@wiseguyreports.com
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune – 411028
Phone: +1-646-845-9349 (US), +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/baby-apparels-market-2018-global-trends-market-share-industry-size-growth-opportunities-and-forecast-to-2023/400172

For more information, please visit https://www.wiseguyreports.com/sample-request/3339077-global-baby-apparels-market-insights-forecast-to-2025

Source: MarketersMedia

Release ID: 400172